Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $4.78 billion. The enterprise value is $4.65 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 48.46 million shares outstanding. The number of shares has increased by 7.10% in one year.
| Current Share Class | 48.46M |
| Shares Outstanding | 48.46M |
| Shares Change (YoY) | +7.10% |
| Shares Change (QoQ) | +1.19% |
| Owned by Insiders (%) | 1.41% |
| Owned by Institutions (%) | 72.76% |
| Float | 36.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.88 |
| Forward PS | 8.59 |
| PB Ratio | 51.45 |
| P/TBV Ratio | 147.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of 2.07.
| Current Ratio | 2.44 |
| Quick Ratio | 2.30 |
| Debt / Equity | 2.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -48.58 |
Financial Efficiency
Return on equity (ROE) is -171.61% and return on invested capital (ROIC) is -41.52%.
| Return on Equity (ROE) | -171.61% |
| Return on Assets (ROA) | -26.44% |
| Return on Capital (ROIC) | -41.52% |
| Revenue Per Employee | $621,022 |
| Profits Per Employee | -$570,560 |
| Employee Count | 545 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.49 |
Taxes
| Income Tax | -325,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.75% in the last 52 weeks. The beta is 1.25, so AXSM's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +66.75% |
| 50-Day Moving Average | 90.99 |
| 200-Day Moving Average | 82.63 |
| Relative Strength Index (RSI) | 62.20 |
| Average Volume (20 Days) | 568,489 |
Short Selling Information
The latest short interest is 7.58 million, so 15.64% of the outstanding shares have been sold short.
| Short Interest | 7.58M |
| Short Previous Month | 7.52M |
| Short % of Shares Out | 15.64% |
| Short % of Float | 20.91% |
| Short Ratio (days to cover) | 18.44 |
Income Statement
In the last 12 months, AXSM had revenue of $338.46 million and -$310.96 million in losses. Loss per share was -$6.53.
| Revenue | 338.46M |
| Gross Profit | 308.29M |
| Operating Income | -245.87M |
| Pretax Income | -309.56M |
| Net Income | -310.96M |
| EBITDA | -244.62M |
| EBIT | -245.87M |
| Loss Per Share | -$6.53 |
Full Income StatementBalance Sheet
The company has $327.34 million in cash and $192.30 million in debt, giving a net cash position of $135.04 million or $2.79 per share.
| Cash & Cash Equivalents | 327.34M |
| Total Debt | 192.30M |
| Net Cash | 135.04M |
| Net Cash Per Share | $2.79 |
| Equity (Book Value) | 92.90M |
| Book Value Per Share | 1.92 |
| Working Capital | 282.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$132.57 million and capital expenditures -$247,000, giving a free cash flow of -$132.82 million.
| Operating Cash Flow | -132.57M |
| Capital Expenditures | -247,000 |
| Free Cash Flow | -132.82M |
| FCF Per Share | -$2.74 |
Full Cash Flow StatementMargins
Gross margin is 91.09%, with operating and profit margins of -72.65% and -91.87%.
| Gross Margin | 91.09% |
| Operating Margin | -72.65% |
| Pretax Margin | -91.97% |
| Profit Margin | -91.87% |
| EBITDA Margin | -72.28% |
| EBIT Margin | -72.65% |
| FCF Margin | -57.64% |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.10% |
| Shareholder Yield | -7.10% |
| Earnings Yield | -6.50% |
| FCF Yield | -2.78% |
Dividend DetailsAnalyst Forecast
The average price target for AXSM is $124.93, which is 26.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $124.93 |
| Price Target Difference | 26.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 50.09% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 1.89 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.89 |
| Piotroski F-Score | 2 |